NasdaqGS - Delayed Quote USD

ZimVie Inc. (ZIMV)

17.02 +0.04 (+0.24%)
At close: May 17 at 4:00 PM EDT
17.02 0.00 (0.00%)
After hours: May 17 at 4:20 PM EDT
Loading Chart for ZIMV
DELL
  • Previous Close 16.98
  • Open 17.14
  • Bid 16.97 x 200
  • Ask 17.04 x 200
  • Day's Range 16.83 - 17.24
  • 52 Week Range 6.52 - 20.91
  • Volume 230,363
  • Avg. Volume 334,307
  • Market Cap (intraday) 464.454M
  • Beta (5Y Monthly) 2.00
  • PE Ratio (TTM) --
  • EPS (TTM) -1.92
  • Earnings Date Jul 31, 2024 - Aug 5, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 18.00

ZimVie Inc., together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment. The company offers dental implant systems, prosthetic and abutment products, surgical instrumentation, and kits; and patient-specific restorative solutions, such as abutments, bars, implant bridges, and hybrid restorations under the BellaTek brand name. It provides bone grafts, barrier membranes, and collagen wound care products; virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and intra-oral scanners; and Implant Concierge, a web-based treatment planning and surgery guide service. In addition, the company designs, manufactures, and distributes spinal fusion implants, instrumentation for various spinal procedures, biologics, and bone healing technologies. Further, it provides MIS solutions that deliver implant and instrumentation systems; and motion preservation solutions that offer non-fusion alternatives for cervical disc implant or growth modulation for anterior vertebral body tethering. The company sells its products to oral surgeons, dental specialists, general dentists, dental laboratories, and other dental organizations, including DSOs, as well as educational, medical, and governmental entities, hospitals, and surgery centers through direct sales representatives, agents, and distributors. ZimVie Inc. was incorporated in 2021 and is headquartered in Westminster, Colorado.

www.zimvie.com

2,600

Full Time Employees

December 31

Fiscal Year Ends

Recent News: ZIMV

Performance Overview: ZIMV

Trailing total returns as of 5/17/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

ZIMV
4.11%
S&P 500
11.18%

1-Year Return

ZIMV
69.86%
S&P 500
29.04%

3-Year Return

ZIMV
31.92%
S&P 500
18.51%

5-Year Return

ZIMV
31.92%
S&P 500
18.51%

Compare To: ZIMV

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ZIMV

Valuation Measures

Annual
As of 5/17/2024
  • Market Cap

    464.45M

  • Enterprise Value

    943.49M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.00

  • Price/Book (mrq)

    1.20

  • Enterprise Value/Revenue

    2.07

  • Enterprise Value/EBITDA

    13.47

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -81.52%

  • Return on Assets (ttm)

    -0.30%

  • Return on Equity (ttm)

    -9.04%

  • Revenue (ttm)

    455.22M

  • Net Income Avi to Common (ttm)

    -51.16M

  • Diluted EPS (ttm)

    -1.92

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    43.53M

  • Total Debt/Equity (mrq)

    134.57%

  • Levered Free Cash Flow (ttm)

    12.29M

Research Analysis: ZIMV

Company Insights: ZIMV

Research Reports: ZIMV

People Also Watch